PMC9794418_01
Fundus image and fundus autofluorescence of right eye on initial presentation (a, d), right eye 6 years later:prior to fluocinolone acetonide intravitreal implant:(b, e), and right eye 15 months after fluocinolone acetonide intravitreal implant (c, f).
CRIOPM2022-3962221.001.jpg
PMC9794418_01_CRIOPM2022-3962221.001.jpg
fig1
OD (Figure 1). Upon evaluation 15 months after fluocinolone acetonide implant placement, there was no recurrence of inflammation evident (Figures 1 and 2), and repeat assessment at 20 months revealed stability of findings.
Optical coherence tomography (OCT) of the right eye on initial presentation (a), right eye 6 years later:prior to fluocinolone acetonide intravitreal implant:(b), and right eye 15 months after fluocinolone acetonide intravitreal implant (c).
CRIOPM2022-3962221.002.jpg
PMC9794418_01_CRIOPM2022-3962221.002.jpg
fig2
Optical coherence tomography (OCT) revealed temporal outer retinal atrophic changes without fluid OD (Figure 2). On fluorescein angiography, these lesions exhibited early hypofluorescence with late staining at the edges in both eyes. Upon evaluation 15 months after fluocinolone acetonide implant placement, there was no recurrence of inflammation evident (Figures 1 and 2), and repeat assessment at 20 months revealed stability of findings.